---
$id: https://graph.org.ai/products/commodity/51172148
$type: Product
source: UNSPSC
code: "51172148"
title: "Rociverine"
class: "51172100"
classTitle: "Antispasmodics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rociverine

**UNSPSC Code**: 51172148
**Class**: [Antispasmodics](Antispasmodics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antispasmotic agent with the molecular formula C20H37NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VI08KS44V0, chemically known as (1,1-bicyclohexyl)-2-carboxylic acid, 1-hydroxy-, 2-(diethylamino)-1-methylethyl ester but generally known as rociverine, which bears US NIH Compound Identifier 68705. European Medicines Agency schedules Rociverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10352MIG. The term ROCIVERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules rociverine in its Anatomical Therapeutic Chemical (ATC) Classification. ROCIVERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rociverine under HS 29221980 and SITC 51461. As of Q4 2014, ROCIVERINE remains the US FDA Preferred Term for this commodity. Rociverine bears US NLM identifiers UMLS ID C0073547 and NCI Concept Code C90767. SMILES: OC1(C2CCCCC2)C(CCCC1)C(=O)OC(CN(CC)CC)C.

